Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec
NCT02014441
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Interventions
DRUG:
Talimogene laherparepvec
Sponsor
Amgen